Table 2.
Comparative analysis according to presence of symptoms
| Asymptomatic | Symptomatic | P value | |
|---|---|---|---|
| (n = 21) | (n = 17) | ||
| Age (years) | 47.9 ± 12.6 | 51.7 ± 15.9 | 0.416 |
| Gender, n (%) | 0.726 | ||
| Female | 15 (71.4%) | 13 (76.5%) | |
| Male | 6 (28.6%) | 4 (23.5%) | |
| Tumor size (cm) | 3.6 ± 1.9 | 5.3 ± 3.4 | 0.091 |
| Tumor location, n (%) | 0.005 | ||
| Proximal | 3 (14.3%) | 10 (58.8%) | |
| Distal | 18 (85.7%) | 7 (41.2%) | |
| Surgery 1, n (%) | 0.955 | ||
| Open | 15 (71.4%) | 12 (70.6%) | |
| MIS* | 6 (28.6%) | 5 (29.4%) | |
| Surgery 2, n (%) | 0.020 | ||
| Enucleation | 3 (14.3%) | 2 (11.8%) | |
| PD | 0 | 5 (29.4%) | |
| PPPD | 1 (4.8%) | 3 (17.6%) | |
| DPS | 10 (47.6%) | 2 (11.8%) | |
| DP-S | 7 (33.3%) | 5 (29.4%) | |
| Operation time (min) | 203.6 ± 86.8 | 311.2 ± 135.3 | 0.009 |
| Bleeding (ml) | 339.4 ± 351.7 | 662.5 ± 780.5 | 0.153 |
| Transfusion | 0.003 | ||
| No | 19 (90.5%) | 8 (47.1%) | |
| Yes | 2 (9.5%) | 9 (52.9%) | |
| LOH (day) | 12.2 ± 6.1 | 18.5 ± 12.9 | 0.059 |
| Complication, n (%) | 0.736 | ||
| No | 17 (81%) | 13 (76.5%) | |
| Yes | 4 (19%) | 4 (23.5%) |
* MIS minimally invasive surgery, including laparoscopic and robotic
PD pancreatoduodenectomy, PPPD pylorus-preserving pancreatoduodenectomy, DPS distal pancreatectomy with splenectomy, DP-S distal pancreatectomy without splenectomy, LOH length of hospital stay